Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
4 results
Filters applied: . Clear all
Page 1
The minor gentamicin complex component, X2, is a potent premature stop codon readthrough molecule with therapeutic potential.
PLoS One. 2018 Oct 25;13(10):e0206158. doi: 10.1371/journal.pone.0206158. eCollection 2018.
PLoS One. 2018.
PMID: 30359426
Free PMC article.
The known oto- and nephrotoxicity associated with aminoglycosides preclude long-term use as readthrough agents. Thus, we evaluated the components of the gentamicin complex as well as the so-called "designer" aminoglycoside, NB124, for in vitro and in vivo safety. ...
The known oto- and nephrotoxicity associated with aminoglycosides preclude long-term use as readthrough agents. Thus, we evaluated th …
The relationship between deficit in digit span and genotype in nonsense mutation Duchenne muscular dystrophy.
Thangarajh M, Elfring GL, Trifillis P, McIntosh J, Peltz SW; Ataluren Phase 2b Study Group.
Thangarajh M, et al. Among authors: peltz sw.
Neurology. 2018 Sep 25;91(13):e1215-e1219. doi: 10.1212/WNL.0000000000006245. Epub 2018 Aug 22.
Neurology. 2018.
PMID: 30135256
Free PMC article.
Clinical Trial.
Item in Clipboard
Phase 2a study of ataluren-mediated dystrophin production in patients with nonsense mutation Duchenne muscular dystrophy.
Finkel RS, Flanigan KM, Wong B, Bönnemann C, Sampson J, Sweeney HL, Reha A, Northcutt VJ, Elfring G, Barth J, Peltz SW.
Finkel RS, et al. Among authors: peltz sw.
PLoS One. 2013 Dec 11;8(12):e81302. doi: 10.1371/journal.pone.0081302. eCollection 2013.
PLoS One. 2013.
PMID: 24349052
Free PMC article.
Clinical Trial.
INTERPRETATION: Ataluren showed activity and safety in this short-term study, supporting evaluation of ataluren 10, 10, 20 mg/kg and 20, 20, 40 mg/kg in a Phase 2b, double-blind, long-term study in nonsense mutation DMD. ...
INTERPRETATION: Ataluren showed activity and safety in this short-term study, supporting evaluation of ataluren 10, 10, 20 mg/kg and …
Item in Clipboard
Characterization of cis-acting sequences and decay intermediates involved in nonsense-mediated mRNA turnover.
Hagan KW, Ruiz-Echevarria MJ, Quan Y, Peltz SW.
Hagan KW, et al. Among authors: peltz sw.
Mol Cell Biol. 1995 Feb;15(2):809-23. doi: 10.1128/MCB.15.2.809.
Mol Cell Biol. 1995.
PMID: 7823948
Free PMC article.
One clear example of this relationship is the observation that nonsense mutations can accelerate the decay of mRNAs in a process that we term nonsense-mediated mRNA decay. The experiments described here demonstrate that in the yeast Saccharomyces cerevisiae premature trans …
One clear example of this relationship is the observation that nonsense mutations can accelerate the decay of mRNAs in a process that we …
Item in Clipboard
Cite
Cite